Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
We estimated HCV reinfection rates among PWID in Scotland pre and post-introduction of DAAs.
Reduction in the population prevalence of HCV viraemia among people who inject drugs associated with scale-up of direct-acting antiviral therapy in community drug services: real world data
We assessed the impact of rapid DAA scale‐up to PWID delivered through community services in the Tayside region of Scotland.
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study
We examined the impact of the introduction of direct-acting antiviral (DAA) therapies on hepatitis C related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.